Clinical TrialsSearch results
Number of results: 66336
Completed
- A phase 2 study of osimertinib in elderly patients with non-small-cell lung cancer
- advanced / recurrent non-small cell lung cancer (NSCLC)
- Uchino Junji
- 2018-09-03
Completed
- A phase 2 study of VLPCOV-01 in COVID-19 vaccinated healthy subjects
- Prevention of infectious disease caused by SARS-CoV-2
- Sato Nobuaki
- 2022-09-12
Completed
- A Phase 2 study to assess the safety, immunogenicity and recommended dose of DS-5670a in Japanese healthy adults
- Prevention of infectious disease by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
- Inoguchi Akihiro
- 2021-10-29
Completed
- A Phase 2 Study to Evaluate the Efficacy and Safety of BPN14770 in Participants with Mild Alzheimer's Disease
- mild Alzheimer's disease
- Nagata - Tsutae
- 2021-06-14
Completed
- A Phase 2, Multicenter, Global, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Cendakimab (CC-93538) in Adult Subjects with Moderate to Severe Atopic Dermatitis.
- Moderate to severe Atopic dermatitis (AD)
- Changliang Zhang
- 2021-05-25
Completed
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate REduction in Inflammation in PatientS With Advanced Chronic Renal Disease Utilizing Antibody-MEdiated Interleukin-6 Inhibition in Japan (NN6018-4776)
- Chronic kidney disease
- Kanmuri Kazuhiro
- 2020-11-25
Completed
- A Phase 2a Study Assessing the Efficacy and Safety of STN1010905 Ophthalmic Suspension in Subjects with MGD
- MGD (Meibomian Gland Dysfunction)
- Migita Yukie
- 2021-10-08
Completed
- A phase 2a study of S-637880 in patients with neuropathic low back pain
- Neuropathic low back pain
- Nagata - Tsutae
- 2021-03-12
Completed
- A Phase 2b Multinational, Randomised, Double-blind, Parallel-group, 24-week Placebo-controlled Study With 28-week Extension to Investigate the Use of Benralizumab in Patients With Moderate to Severe Chronic Spontaneous Urticaria (ARROYO)
- Chronic Spontaneous Urticaria
- Yamaji Shigeyuki
- 2021-01-25
Completed
- A Phase 2b Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, Dose-Ranging Study of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
- Chronic Kidney Disease
- Hibi Kazushige
- 2020-11-16